| Nov 4 |
CareDx: Q3 Earnings Snapshot
|
| Nov 4 |
CareDx Non-GAAP EPS of $0.14 beats by $0.13, revenue of $82.88M beats by $2.17M
|
| Nov 4 |
CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance
|
| Nov 3 |
CareDx Q3 2024 Earnings Preview
|
| Oct 23 |
CareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching with Cutting-Edge Hi-C Technology
|
| Oct 21 |
CareDx Showcases Latest Advancements Across its HLA Typing Solutions at Annual American Society for Histocompatibility and Immunogenetics Meeting
|
| Oct 16 |
CareDx Reports Strong Q3 2024 Revenue Growth
|
| Oct 15 |
CareDx guides Q3 revenue above estimates
|
| Oct 15 |
CareDx Reports Preliminary Financial Results for Third Quarter 2024
|
| Oct 10 |
CareDx stock climbs 7% amid reports Natera not pursuing litigation
|
